Starling Oncology, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $27.3K | $50.0K | $0 |
| FY2020 | $17.8M | $231.8M | $900.0K |
| FY2021 | $99.3M | $203.4M | $115.2M |
| FY2022 | $138.5M | $261.7M | $14.0M |
| FY2023 | $152.2M | $209.2M | $33.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $27.3K | $50.0K | $0 |
| FY2020 | $17.8M | $231.8M | $900.0K |
| FY2021 | $99.3M | $203.4M | $115.2M |
| FY2022 | $138.5M | $261.7M | $14.0M |
| FY2023 | $152.2M | $209.2M | $33.5M |